Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Burgess

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Lancet. Infectious Diseases|November 21, 2017
Ebola virus disease: an update on post-exposure prophylaxisWilliam A Fischer, Pauline Vetter, Daniel G Bausch, et al.
Frontiers in Neurology|October 30, 2025
Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case-control datasetBenjamin C Pierson, Megan Clare Craig-Kuhn, Laveta Stewart, et al.
Vaccine|March 5, 2011
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adultsNancy F Crum-Cianflone, Erik Iverson, Gabriel Defang, et al.
Open Forum Infectious Diseases|February 8, 2021
SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 PandemicTahaniyat Lalani, Tida K Lee, Eric D Laing, et al.
Research Square|December 3, 2020
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactionsEric Laing, Spencer Sterling, Stephanie Richard, et al.
Open Forum Infectious Diseases|January 14, 2026
Healthcare Workers Have More Frequent and Less Severe Influenza-Like Illness Than Non-healthcare Workers: Findings From the PAIVED StudyRyan Liberg, Kat Schmidt, Christina Schofield, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Frontiers in Immunology|September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durabilityElizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Lancet. Infectious Diseases|November 21, 2017
Ebola virus disease: an update on post-exposure prophylaxisWilliam A Fischer, Pauline Vetter, Daniel G Bausch, et al.
Frontiers in Neurology|October 30, 2025
Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case-control datasetBenjamin C Pierson, Megan Clare Craig-Kuhn, Laveta Stewart, et al.
Vaccine|March 5, 2011
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adultsNancy F Crum-Cianflone, Erik Iverson, Gabriel Defang, et al.
Open Forum Infectious Diseases|February 8, 2021
SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 PandemicTahaniyat Lalani, Tida K Lee, Eric D Laing, et al.
Research Square|December 3, 2020
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactionsEric Laing, Spencer Sterling, Stephanie Richard, et al.
Open Forum Infectious Diseases|January 14, 2026
Healthcare Workers Have More Frequent and Less Severe Influenza-Like Illness Than Non-healthcare Workers: Findings From the PAIVED StudyRyan Liberg, Kat Schmidt, Christina Schofield, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Frontiers in Immunology|September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durabilityElizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.
Pageof 5